Navigation Links
Contemporary Therapeutic Guidelines For HIV Patients

In its quest to vanquish the big time killer AIDS/ HIV infection worldwide Center for AIDS Research at Case Medical Center spearheaded// by Dr Benigno Rodriguez M.D and his extensive team of experts on AIDS/HIV in the U. S. have presented their latest findings in the current issue of Journal Of American Medical Association. Current therapeutic guidelines have been questioned by the latest findings, which contest that the measurement of HIV particles in the blood does not necessarily assess patient’s capability to resist the disease. The current study reiterates the amount of HIV particles (referred to as “viral load” in medical terminology) is not solely to be banked on to assess the rate at which the much valued CD4 cells essential to fight the infection is depleted from the body as a sequel to infection as previously understood.

CD4 cells are white blood cells in the human body, which has a defensive role against invading infection-causing agents. When these cells come under the attack of Human Immunodeficiency Virus, their numbers decline. Following this the symptoms associated with AIDS become more pronounced. The study conducted elucidates that the viral load could account for only 5% of variations in CD4 loss from patient to patient. Therefore it was concluded that the viral load couldn’t be held as sole culprit responsible for bringing down the CD4 count.

Source-Eurekalert
RM
'"/>




Page: 1

Related medicine news :

1. Understanding Chronic Infections May Help in Developing Therapeutic Vaccines
2. Therapeutic cloning by regenerating stem cells from heart muscles
3. Therapeutic Genes Transferred By Viral Vector Through T Cell Masking
4. Therapeutic Monoclonal Antibody Production Is More Profitable Than Small Molecule Drugs
5. Functional Differences In Estrogen Receptor Could Be A Therapeutic Target
6. Clinical-trials Show Increased Therapeutic Activity of Pycnogenol than Daflon
7. Safety of Cancer Therapeutic Viruses Enhanced
8. Researchers Enhance Safety and Effectiveness of Therapeutic Virus that Fights Cancer
9. Human Embryonic Stem Cells Could Be Later Used In Therapeutic Cloning
10. Potential New Therapeutic Target for Asthma, Allergies and Cancer
11. VBI Provides Potential Targets to Diabetes Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced ... test throughout the Northeast U.S. , GlycoMark is the only clinically available ... test provides a clinically proven one- to two-week measure of hyperglycemic excursions, often ...
(Date:4/28/2017)... ... 28, 2017 , ... Children and adolescents who enter the ... children in the general population. That’s because foster care is designed to protect ... While no fault of their own, youth who have experienced trauma often have ...
(Date:4/28/2017)... ... April 28, 2017 , ... Bill Howe started his sewer and drain ... After Tina Howe joined the team, the Bill Howe brand was born and they ... rates, and giving back to the San Diego community in which they worked, lived ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation ... supplements, through its Nova Skin Sciences division, recently announced the launch of Allumière ... with the power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark ...
(Date:4/27/2017)... ... 27, 2017 , ... Today, Jefferson Health in Philadelphia and ... an agreement to create the Jane and Leonard Korman Respiratory Institute in Philadelphia. ... Korman Family Foundation. The collaboration leverages the strengths of each organization and will ...
Breaking Medicine News(10 mins):
(Date:4/26/2017)... PROVIDENCE, N.J. , April 26, 2017 Phoenix ... announce its fifteenth year of fulfilling its mission of transforming ... industry is highly scrutinized, Phoenix,s innovative ... the healthcare community about the latest advances in science and ... Phoenix was founded in 2002 by ...
(Date:4/21/2017)... 21, 2017 Halo Labs announces the launch ... analysis system called the Horizon at PEGS 2017 in ... new system analyzes sub visible particulate matter in biopharmaceutical ... screening as early as candidate selection and pre-formulation. ... contract research organization Elion Labs for system ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
Breaking Medicine Technology: